Skip Navigation
Every Woman Counts
  Home Contact Us Site Index Search
 CANCER SCREENING
 & DIAGNOSIS
 
  TRAINING CENTER
  
 
  PROFESSIONAL
  RESOURCES
  Patient Education
  Clinical Tools
  On Topic
  Link Library
  ACA Resources
  EWC PROGRAM
 
 
  ABOUT US
 
 
 

Clinical Tools

The Every Woman Counts program recommends, develops, and distributes select clinical tools to clinicians providing breast and/or cervical cancer screening and diagnostic services (see EWC Developed). EWC also reviews and offers selected links to clinical tools developed by national, not-for-profit organizations (see National Sources).

Please Note: Links to external websites will open in a new browser window. Close the window to return to this page.

 

EWC Developed:

Breast Cancer

Cervical Cancer

Top


National Sources:

Breast Cancer

Guide for Clinicians with Patients who Have Dense Breasts
If your patient has mammographically dense breasts, she will be notified per California State Law (SB 1538). This notification may prompt questions regarding the need for supplemental breast cancer screening . Developed by the California Breast Density Information Group, this brief guide helps clinicians identify red flag risk factors that may necessitate further screening and offers suggestions for how to reassure those patients without additional risk factors.

Tier 1 Genomic Applications Toolkit
The Centers for Disease Control and Prevention (CDC) has developed a Tier 1 Genomic Applications Toolkit for public health departments that focuses on specific evidence-based applications for persons at risk of hereditary colorectal cancer due to Lynch syndrome, hereditary breast and ovarian cancer due to BRCA mutations, and cardiovascular disease due to familial hypercholesterolemia. The toolkit provides key background information, tools, and real world examples to help states and their partners build upon existing chronic disease programs.

Cervical Cancer

2012 Updated Consensus Guidelines and Algorithms
The American Society for Colposcopy and Cervical Pathology (ASCCP) has released the 2012 Updated Consensus Guidelines for Managing Abnormal Cervical Cancer Screening Tests and Cancer Precursors. These guidelines follow adoption of updated cervical cancer screening guidelines (2012), incorporating longer screening intervals and cotesting. Algorithms detailing the different management recommendations were also updated and released.

Top

Note: Documents in Portable Document Format (PDF) require Adobe Acrobat Reader 5.0 or higher to view. Download Adobe Acrobat Reader.

Last updated: January 7, 2016

 
Search Site Index Terms Privacy